Monday, May 19, 2008

Genentech Announces June 2 Webcast Discussion of Data Presented at ASCO

SOUTH SAN FRANCISCO, Calif. -- May 19, 2008 --

Genentech, Inc. (NYSE: DNA) invites investors, the media and the general public to listen to an audio webcast discussing data presented during the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Illinois.


The live webcast will begin at 4:00 p.m. Pacific Time on June 2, 2008. The webcast can be accessed on Genentech's website at http://www.gene.com and will be archived and available for replay until 5:00 p.m. Pacific Time on June 16, 2008. A telephonic replay will also be available beginning at 7:30 p.m. Pacific Time on June 2, 2008 through 5:00 p.m. Pacific Time on June 9, 2008. Access numbers for this replay are: 1-800-642-1687 (U.S./Canada) and 1-706-645-9291 (international); Conference ID number is 47920264.


About Genentech
Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with significant unmet medical needs. The company has headquarters in South San Francisco, California and is listed on the New York Stock Exchange under the symbol DNA. For additional information about the company, please visit http://www.gene.com.

# # #